Covid 19

India helped Brazil in the hour of need during Covid

  • October 21, 2021
  • 2 mins read

In the peak time of the Covid pandemic outbreak, countries like Brazil sought a shortage of essential medicines and medical aids. The National Association of Private Hospitals (Anahp) conducted a new survey with its member hospitals to identify the lack of medication and supplies to treat patients infected from coronavirus. 71 institutions participated in this survey, and the conclusion is that the situation was still critical. About 30% of hospitals had a stock of anesthetic and “intubation kit” for only five days or less.

To overcome this shortage, hospitals looked for an alternative to import medicines and other medical aids from India, the only country capable of supplying the Brazilian pharmaceutical market requirements. India is known as one of the largest generic medicine manufacturers in the World, and in those crucial times, India helped Brazil meet its required demands. India helped Brazil keeping in mind the rules and regulations, and Anvisa (National Health Surveillance Agency) helped by providing solutions to bureaucratic obstacles in facilitating prerequisite treatments at the time.

The significant role played by Ikris during the Covid-19 pandemic.

According to the survey conducted, Brazil urgently needed oxygen, anesthetic medicines, an intubation kit including a set of anesthetics, sedatives and muscle blockers, and ICU beds due to critical Covid-19 cases. India helped Brazil in every way possible. Ikris Pharma Network, an international pharmaceutical organization was the top organization that came forward to help Brazil in those tough times of pandemic outbreaks to export the requisite drugs and medical equipment. Ikris Pharma has always been a trusted supplier of medications and medical services. It is always there to provide medical facilities to the clients as quickly as possible as Ikris works with a mantra that each life counts. It works strictly according to the rules and regulations and works legally, with quality products and providing medications with zero adulteration.
There are numerous medicines or drugs needed in Brazil in Covid-19 times in 2020-2021 and are still continuously helping the Brazilian pharmaceutical market by exporting medicines and products. Ikris deals in medicine related to Oncology, Hepatology, Genetics, Transplant, Hematology, Ophthalmology, Neurology, Immunology, Nephrology, etc.
Ikris has supplied many medicines and is already exporting other required medication to the Brazilian health sector. It is looking forward to helping Brazil like this in the coming future with quality rare medicines. The motto of Ikris is “access is a right, not a privilege”.

Survey on Export from India to Brazil in pharma products

According to the United Nations COMTRADE database on international trade, India’s Exports of pharmaceutical products to Brazil were US$320.93 Million during 2020. Here is the data on India Exports of pharmaceutical products to Brazil, and it was last updated in October of 2021.